Both metformin, an antidiabetic drug, and everolimus, an mTOR inhibitor, suppressed TNT formation in ovarian tumor-derived epithelial and ovarian adenocarcinoma cells [155]. This evidence concerns the gene MTOR and ovarian adenocarcinoma.